Abstract
The incidence of head and neck cancer increases every year, and represents a significant problem for Molecular Biology at the beginning of the Twenty-first Century. Despite advances in treatment, most studies still strive to deepen the understanding of the mechanisms of cancerogenesis. In order to develop more effective methods of diagnosis and therapy, it is necessary to understand the molecular basis of the neoplastic transformation process. Such findings obtained by research into Molecular Biology, Molecular Epidemiology and Genetics have brought significant progress in understanding the complex, multi- step process which takes place during tumor formation. For many years, there has been great interest in the use of complex compounds, particular complexes between heterocyclic compounds and the metals Pt (II), Pd (II), Cu (II) and Ru (III). One such compound is an azole called pyrazole; the azoles are known to have analgesic, antipyretic, anti-tumor, anti-inflammatory and anti-fungal effects. Improved synthetic and separation methods and biochemical techniques have improved the identification of compounds with biological activity. The main aim of this review is to present complexes with Pt (II), Pd (II), Cu (II) and Ru (III) ions which demonstrate antioxidant and anti-cancer properties.
Keywords: Pyrazoles, complexes of Pt(II), Cu(II), Ru(III) and Pd(II), antioxidant, anticancer properties, antioxidative barrier, chemiotherapeutics.
Mini-Reviews in Medicinal Chemistry
Title:An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy
Volume: 18 Issue: 16
Author(s): Malinowska Katarzyna, Szczepanska Anna*, Hanna Zielinska-Blizniewska and Majsterek Ireneusz
Affiliation:
- Department of Chemistry and Clinical Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz,Poland
Keywords: Pyrazoles, complexes of Pt(II), Cu(II), Ru(III) and Pd(II), antioxidant, anticancer properties, antioxidative barrier, chemiotherapeutics.
Abstract: The incidence of head and neck cancer increases every year, and represents a significant problem for Molecular Biology at the beginning of the Twenty-first Century. Despite advances in treatment, most studies still strive to deepen the understanding of the mechanisms of cancerogenesis. In order to develop more effective methods of diagnosis and therapy, it is necessary to understand the molecular basis of the neoplastic transformation process. Such findings obtained by research into Molecular Biology, Molecular Epidemiology and Genetics have brought significant progress in understanding the complex, multi- step process which takes place during tumor formation. For many years, there has been great interest in the use of complex compounds, particular complexes between heterocyclic compounds and the metals Pt (II), Pd (II), Cu (II) and Ru (III). One such compound is an azole called pyrazole; the azoles are known to have analgesic, antipyretic, anti-tumor, anti-inflammatory and anti-fungal effects. Improved synthetic and separation methods and biochemical techniques have improved the identification of compounds with biological activity. The main aim of this review is to present complexes with Pt (II), Pd (II), Cu (II) and Ru (III) ions which demonstrate antioxidant and anti-cancer properties.
Export Options
About this article
Cite this article as:
Katarzyna Malinowska, Anna Szczepanska*, Zielinska-Blizniewska Hanna and Ireneusz Majsterek, An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy, Mini-Reviews in Medicinal Chemistry 2018; 18 (16) . https://dx.doi.org/10.2174/1389557518666180423145825
DOI https://dx.doi.org/10.2174/1389557518666180423145825 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models
Anti-Cancer Agents in Medicinal Chemistry Connecting A Tumor to the Environment
Current Pharmaceutical Design Study of Parasitic Infections, Cancer, and other Diseases with Mass-Spectrometry and Quantitative Proteome-Disease Relationships
Current Proteomics Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review
Current Drug Targets Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Criteria of Evidence to Move Potential Chemopreventive Agents into Late Phase Clinical Trials
Current Drug Targets Sentinel Node Imaging
Current Medical Imaging Role of Human and Mouse HspB1 in Metastasis
Current Molecular Medicine Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances
Current Cancer Therapy Reviews Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints
Current Molecular Imaging (Discontinued) Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
Current Cancer Drug Targets Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Anti-Angiogenic Agents in Pancreatic Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Methods for Hydroxamic Acid Synthesis
Current Organic Chemistry PET-Evaluated Transport of [11C]Hydroxyurea Across the Rat Blood-Brain Barrier - Lack of Influence of Cyclosporin and Probenecid
Drug Metabolism Letters Protective Effect of Perindopril on Tumor Progression and Angiogenesis in Animal Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery